March 2, 2026

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 54% Upside Potential in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its promising focus on treating metabolic dysfunction-associated steatohepatitis (MASH). With a market cap..

Royalty Pharma plc (RPRX): Investor Outlook with 11.57% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands at a pivotal position in the biotechnology sector, offering a unique investment opportunity through its innovative business model. As a major player in the..

The Ensign Group, Inc. (ENSG) Stock Analysis: Solid Growth Prospects with a 2.91% Potential Upside

The Ensign Group, Inc. (ENSG) is an intriguing player in the healthcare sector, specifically within the medical care facilities industry, where it has carved out a significant presence. With a..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unveiling a 17% Upside Potential for Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is capturing attention in the biotechnology sector with a potential upside of 17.16%, as analysts project a promising future for this Dublin-based company. Known for..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Fresenius Medical Care AG (FMS): Investor Outlook Reveals 17.34% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a global leader in dialysis services and products, stands as a noteworthy player in the healthcare sector, particularly within the medical care facilities industry...

HealthEquity, Inc. (HQY) Stock Analysis: Unveiling a 49.61% Upside Potential

Investors eyeing the healthcare sector may find HealthEquity, Inc. (NASDAQ: HQY) an intriguing proposition, given its robust service offerings and promising market position. Headquartered in Draper, Utah, HealthEquity provides a..

Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside with Strong Buy Ratings

For investors seeking exposure to the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents an intriguing opportunity. With a market cap of $10.26 billion, this Netherlands-based company operates in the diagnostics..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 20.78% Potential Upside in Healthcare

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, is capturing investor attention with a robust market capitalization of $101.65 billion. The company, renowned for its comprehensive healthcare..

Pfizer, Inc. (PFE) Stock Analysis: Navigating the Healthcare Giant’s Growth Potential Amidst a 6.22% Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a stalwart in the healthcare sector, renowned for its robust portfolio of biopharmaceutical products that cater to a wide range of medical needs globally...

Avantor, Inc. (AVTR) Stock Analysis: Unpacking Its 20.36% Potential Upside Amidst Mixed Financials

Avantor, Inc. (NYSE: AVTR) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, with its vast array of mission-critical products and services that cater to..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring the 32% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $4.58 billion, the company is..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 16.36% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (BIO), a prominent player in the healthcare sector, is attracting investor attention with its strong potential upside of 16.36%. As a company operating within the medical devices..

Encompass Health Corporation (EHC) Stock Analysis: A 32% Upside in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC) is a dominant player in the healthcare sector, specifically within the medical care facilities industry. Known for its comprehensive post-acute healthcare services, Encompass Health operates..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Healthcare Giant with a 5.45% Upside Potential

For investors eyeing opportunities in the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents an intriguing option. With a storied history dating back to 1781, this Japanese pharmaceutical behemoth..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a Potential 11.71% Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to solidify its position as a key player in the medical instruments and supplies industry. With a..

Amgen Inc. (AMGN) Stock Report: Evaluating the 106% Return on Equity and Market Prospects

For individual investors keeping a keen eye on the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling case with its impressive return on equity (ROE) of 106.10%, a notable..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth with a 2.28% Upside Potential

Molina Healthcare Inc (NYSE: MOH) is a prominent player in the healthcare sector, specifically within the healthcare plans industry. As of its latest trading session, the company holds a market..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 33.92% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out in the healthcare sector as a dynamic force within the specialty and generic drug manufacturing industry. Headquartered in San Diego, the company has..

ICON plc (ICLR) Stock Analysis: Unpacking the 37% Upside Potential

Investors eyeing the healthcare sector may want to take a closer look at ICON plc (NASDAQ: ICLR), a leading player in the diagnostics and research industry. Headquartered in Dublin, Ireland,..

Search

Funds

March 2, 2026

Search

Funds

March 2, 2026

FTSE 100

Funds